NCT06184464 Prostatic Size Reduction Following of Leuprorelin Acetate
| NCT ID | NCT06184464 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Consorci Sanitari de Terrassa |
| Condition | Prostate Cancer Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-02-02 |
| Primary Completion | 2024-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2024-02-02 with a primary completion date of 2024-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Eligibility Criteria
Inclusion Criteria: Man with Prostate positive biopsy. Able to Ssgned informed consent form. Need of hormonal treatment before start of radiotherapy Exclusion Criteria: Patients With prostate size of less than 20 cc at diagnosis. Patients With Positive lymph nodes or metastatic prostate cancer disease on imaging studies. Patients with Previous pelvic radiation therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06184464 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 95 Years, studying Prostate Cancer Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06184464 currently recruiting?
Yes, NCT06184464 is actively recruiting participants. Contact the research team at nicofeltes_81@hotmail.com for enrollment information.
Where is the NCT06184464 trial being conducted?
This trial is being conducted at Terrassa, Spain.
Who is sponsoring the NCT06184464 clinical trial?
NCT06184464 is sponsored by Consorci Sanitari de Terrassa. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.